chrisvoncsefalvay/vaers-outcomes huggingface dataset:
p/vax pt noticed 6cm red flat circular rash on rt thigh (site of HIB vax);no fever, pruritus;otherwise well;no pain ambulating well;
Patient received Moderna COVID vaccine on 4/20/21 and 10/15/21. On 1/31/22, patient admitted to our inpatient facility with COVID19 acute on chronic hypoxic respiratory failure, seizure, and acute encephalopathy.  As of today (2/1/22), patient is still admitted in the med/surg unit.
Acute to chronic  tonsillitis Tonsils stones Intermittent hoarseness Acute to chronic hands joints pain Left axillary lymphadenopathy
little bit of discomfort if I chewed or spoke; some inflammation of the gland in neck; little bit of swelling on the gland in his neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (little bit of swelling on the gland in his neck), MASTICATION DISORDER (little bit of discomfort if I chewed or spoke) and INFLAMMATION (some inflammation of the gland in neck) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (little bit of swelling on the gland in his neck), MASTICATION DISORDER (little bit of discomfort if I chewed or spoke) and INFLAMMATION (some inflammation of the gland in neck). At the time of the report, LYMPHADENOPATHY (little bit of swelling on the gland in his neck), MASTICATION DISORDER (little bit of discomfort if I chewed or spoke) and INFLAMMATION (some inflammation of the gland in neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were not provided.
Redness, swelling, itching, hard knot at injection site, slight pain upon touch
I am a breast feeding mother of a 11 month old. After breastfeeding my daughter about 6 hours after the injection and the next day as well, my daughter broke out into rash all over her body. Large red spots with white dots. They appeared about 10 minutes after breast feeding. Also, I, myself, got chills and a terrible headache and body aches the night of the injection.
This spontaneous report as received from a male consumer of unknown age referring to himself. None drug reactions, allergies or pertinent medical history were reported. On an unknown date the patient was vaccinated with GARDASIL, dose 3, (route, lot number and expiration date were unspecified). No concomitant therapies were reported. The patient stated that he received his last dose (dose 3) of GARDASIL about 1 year after the second dose. No adverse event reported. The outcome of received his last dose about 1 year after the second dose was unknown. Additional information is not expected because no reporter details were provided.
fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and FATIGUE (fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.
On night of Jan 11, irregular heart rate the entire night.  Again on Jan 14, irregular heart rate entire night.  Went to Dr office on Jan 15.   Blood pressure 176/100.  Do not have high blood pressure. Continued with high blood pressure through Jan 25 with highest blood pressure of 200/110.  Blood pressure went back to normal after that, no additional meds.  On Feb 24, blood pressure spiked at 220/120 and went to Hospital ER.  Blood pressure continues to be high even with new blood pressure medicine prescribed.  Did not receive 2nd dose of vaccine.
8/16 - Parent Denies adverse Reaction to 0.5ml dose given instead of 0/3ml dose.
This patient received a cell phone call from a PA. This PA saw the patient today in the clinic and diagnosed site of injection right deltoid as cellulitis. Treating the patient with Keflex and increased her Celebrex.
An attorney reported that a 57 year old male received either IPV or OPV (manuf unk) sometime in the 1950s or 1960s. He was reportedly diagnosed with mesothelioma on or about November 2000. On 12/22/00, he died from the mesothelioma. It is alleged that, exposure to SV40 in the vaccine was a cause of the pt's mesothilioma. The reporter also noted exposure to asbestos and asbestos containing products as a cause. No further info was available at the date of this report.
PER ID MD NOTE 3/20/2021: He has a number of chronic medical problems.  He was in his usual state of health until February 17 when he was brought to this hospital delirious, febrile and confused.  He received empiric antibiotics.  He improved quickly within a couple of days and was discharged.  His illness began within 1 day after receiving his first dose of the Moderna COVID vaccine.  Again, he was in his usual state of health until March 17 when he developed fevers, chills and delirium.  This was a day after receiving his second dose of the Moderna COVID vaccine.  He was admitted, resuscitated with fluids, empiric antibiotics.  He became short of breath earlier today and got some diuresis with improvement.  ID consult has been requested.
it is on forearm, on some days it is more red, sometimes it is shiny, it feels hard, with a small hard bump and white spot inside; a growing quite beige-red spot on the exact place i got a jab; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE NODULE (it is on forearm, on some days it is more red, sometimes it is shiny, it feels hard, with a small hard bump and white spot inside) and VACCINATION SITE ERYTHEMA (a growing quite beige-red spot on the exact place i got a jab) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NODULE (it is on forearm, on some days it is more red, sometimes it is shiny, it feels hard, with a small hard bump and white spot inside) and VACCINATION SITE ERYTHEMA (a growing quite beige-red spot on the exact place i got a jab). At the time of the report, VACCINATION SITE NODULE (it is on forearm, on some days it is more red, sometimes it is shiny, it feels hard, with a small hard bump and white spot inside) and VACCINATION SITE ERYTHEMA (a growing quite beige-red spot on the exact place i got a jab) had not resolved.            Concomitant and treatment medications were not reported.  The patient got 2 Moderna jabs few years ago and experienced side effects. It was a growing quite beige-red spot on the exact place got a jab. It was on forearm, on some days it was more red, sometimes it was shiny, it feels hard, with a small hard bump and white spot inside. In 3 years, it had grown to approximate 6-7 mm. It was reported that the, current growth rate was 2 mm in a year. The patient visited doctors and they failed to deliver an explanation.
pt started w/bruising on head, proceeding to limbs;seen by MD, blood work done, platelets @ 1000; hosp w/thrombocytopenia, hematologist tx: WHI RHO 700mcg w/inadequate clinical response; recv 14gm IgG; plt inc;d/c home w/ precautions.
Received Influenza vaccine 11/3/06. 11/9/06 had acute onset of facial simple motor tics.
I am not sure if it is coincidence, but a year prior to vaccine it was being questioned rather I had plaque psoriasis.  2 days after I started breaking out on both elbows and now I am pretty sure I have it.  Joint pain is excruciating, and I have several plaques starting.  Not bothersome enough to forgo my second shot, but enough to be worrisome.
Occlusive retinal vasculitis with devastating loss of vision even after treatment with IV solumedrol.  Pt now on immunosuppression.  Vision is Hand Motion OD and 20/400 OS.  Pt noted blurry/foggy vision OD 2 wks (06/9/2021) after 2nd dose.  At 3 wks (06/16/2021), vision became worse and developed foreign body sensation.  At 4 wks (06/22/2021), she "couldn't see." She sought eye care and was eventually referred to the Eye Clinic and first evaluated on 6/25/21 and found to have panuveitis with retinal whitening/necrosis.  She underwent same day diagnostic vitrectomy to rule out infectious causes and was also started on high dose oral prednisone after IV solumedrol 500  mg after surgery.  She initially did better but then started to decline and then underwent IV Solumedrol 1G daily x 3, last dose 7/10/21 with some recovery of vision OS to 20/400. Presenting vision was Counting Fingers @ 5 Ft in both eyes. She is now on Humira and mycophenolate mofetil, and has received intravitreal ozurdex injections.
Thigh edema/erythema. Questionable cellulitis. Treated with Benadryl.
I still have a large, looks like a bruise but more purple; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 2 via an unspecified route of administration on 01Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced i still have a large, looks like a bruise but more purple on an unspecified date (I got my Pfizer my second shot. It is been 8 days ago now and I still have a large, looks like a bruise but more purple. The patient was asking Is that normal). Outcome of the event was unknown.  Information on the Lot/Batch Number has been requested.  Follow-up attempts are completed. No further information is expected.
pt within 1 week of having covid vaccination had a subclavicular lymph node start swelling. she is seeing me 1 wk later and she states it has grown. it is 1cm  unknown if this is vaccine related or not but due to timing, felt it should be reported
Severe swelling and in left shoulder. Limited mobility in arm. Cannot move arm with being in pain.
Two events of headache and fatigue and slight face flushing.  First day of 2nd shot and day after 2nd shot.  March 26 and March 27. Second event 6 and 7 days after 2nd shot.  April 1 and April 2. Felt fine in between.
57 y/o F with PMHx of breast CA, crohns and colitis began to feel a lightheaded, anxious and palpitations around 32 minutes after receiving the vaccine. Patient stated that she previously had a delayed reaction to vaccines (about 3-4 hours after) and stated that she experienced peripheral and mild facial edema. She was immediately assessed by PA and medics on site. She appeared anxious and shaking "from the nerves". She was placed on the stretcher, given 2 L of O2 via NC and vitals were taken. EKG was taken and did not show any irregularities. Denies HA, chest pain, dyspnea, SOB, n/t/p, chest tightness, n/v, abd pain. s/p 55 min after receiving the vaccine, she began to clear her throat "as if something was stuck in it. She denied sensation of tightness or like it was closing up but stated it was irritating her.  Clinical team decided it was best to transport her to hospital for further evaluation consider her past history of delayed reactions to vaccines.
(R) arm swelling, erythema, pain, rash-started Wednesday evening, less than 12 hrs after shot; treatment - prednisone and Abx.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 09-JUN-2016 the patient was vaccinated with an improperly stored dose of GARDASIL single-dose vial (SDV) lot # L035105 expiration date 14-MAY-2017, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 24 hours with the highest recorded temperature of 30.8 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
3/26: Shortness of breath symptoms noted. Symptoms continued until 3/31: Noted significant increase in severity of symptoms of difficulty breathing. 4/1: Urgent care visit followed by chest xray and hospital admission for Spontaneous pneumothorax (Right). Chest Tube Inserted and discharged 4/3.  4/20: Followup visit with Dr. - order received for a followup chest xray.  4/22: Followup Chest xray showed small pneumo. Under observation with followup chest xray ordered for 4/27.
A non-serious spontaneous report of H1N1 LAIV inadvertently administered to 62 year old was received from a health professional concerning a 62-year-old patient of unknown gender. No past medical history or concomitant medication was reported for this patient. The patient received H1N1, Intranasal for an unknown indication between 24-Oct-2009 and 05-Nov-2009. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Headaches and nausea 30 minutes after injection. Next day  numbness sensation on hands and anxiety. Patient evaluated in the ER department. Ondansetron given for nausea. Patient recovered without complication afterwards.
Flushing - within 5 minutes of injection, resolved within 15 minutes. Muscle soreness at injection site, swelling at injection site - began about an hour after injection, still sore and mildly swollen 24 hours later. Dizziness, nausea, general muscle aches - began in the evening after injection, continuing 24 hours after injection (all symptoms are mild).
I had a migraine on April 10 and 14, and I started to get one on the morning of April 16, but took migraine medication (Rizatriptan) and was able to head that one off.  I typically get only about 1 migraine every year or two, so to get three in one week is unprecedented for me.  It remains to be seen if I'll continue to have them, and I certainly won't be taking the second COVID vaccine.
First shot Sept 2018 / did not receive the 2nd shingles shot / never got shot #2; Recently got shingles / About 2.5 weeks ago she got a / light case of shingles; About 2.5 weeks ago she got a rash; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. In September 2018, the patient received the 1st dose of Shingles vaccine. On an unknown date, not applicable after receiving Shingles vaccine and more than a year after receiving Shingles vaccine, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient had first dose of shingles and due to confusion between the second shot for shingles and the second shot of the pneumonia vaccine, never received the second shingles vaccine, which led to incomplete course of vaccination. The patient recently experienced Shingles and asked if now he/she could receive 2nd dose of Shingles vaccine. The patient consented to follow up.  Follow up information received from consumer on 28th May 2021: The patient's demographic details were updated. The patient's family had history of Shingles where her mother and sister both had shingles. The patient stated that, she had first dose of Shingrix in 2018 and never received second dose. The patient reported about 2.5 weeks ago of reporting, she had rash which ended up being a light case of shingles.
red knot; screen was blurry; covid arm; big red 2 inch circle on arm; really really sore; This spontaneous case was reported by a consumer and describes the occurrence of NODULE (red knot), VISION BLURRED (screen was blurry), VACCINATION SITE REACTION (covid arm), VACCINATION SITE ERYTHEMA (big red 2 inch circle on arm) and VACCINATION SITE PAIN (really really sore) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 013A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU VACCINE VII (Flu shot was taken in left arm and is still sore.). Concomitant products included GABAPENTIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NODULE (red knot), VISION BLURRED (screen was blurry), VACCINATION SITE REACTION (covid arm), VACCINATION SITE ERYTHEMA (big red 2 inch circle on arm) and VACCINATION SITE PAIN (really really sore). At the time of the report, NODULE (red knot), VACCINATION SITE ERYTHEMA (big red 2 inch circle on arm) and VACCINATION SITE PAIN (really really sore) had not resolved and VISION BLURRED (screen was blurry) and VACCINATION SITE REACTION (covid arm) outcome was unknown.            No treatment medications were provided.  Action taken in response to mRNA-1273 is considered to be not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: FU received, Possibly NNI
Intense pain in left arm and shoulder radiating down to hand. I am unable to raise my left arm more than a few inches. I cannot sleep on my left side without excruciating pain. It is now 48 hours after my Pneumovax 23 injection in my upper left arm and I am still in excruciating pain. I called and reported this to Pharmacy on 12/11/2016 at 10:30 AM and the Pharmacist said she had never heard of this type of reaction and that there must be some sort of inflammation going on where the injection was given. She told me to ice the arm and take an anti-inflammatory medication like Advil. She said she would investigate and call me back. I still have heard nothing......I am calling my Primary Care Doctor tomorrow. I have never had this type of reaction from a shot before. I have had the flu shot with no difficulty and also 1 year ago the Previlar 13 Pneumonia Vaccine with no problem. On a scale of 1 to 10 this pain and lack of being able to move my whole arm without excruciating pain is horrible.
large knot on the injection site, some redness and itching occured that day around noon on 2/05/2021. I still have the same symptoms on 2/13/2021
Pt recvd flu vax @ 530PM 26NOV91 went to chinese restuarant for dinner right p/vax ate full meal; went to bed @ 9PM awoke 930PM w/severe SOB, cyanosis, inc mucous production; went to ER was told probably MSG rxn-instead of flu vax;
The vial was first punctured on 04-AUG-2022 at 8:15 AM and administerd on 25-AUG-2022 at at 8:30 AM; No adverse event; Pediatric patient received dose greater than 12 hour post puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pediatric patient received dose greater than 12 hour post puncture), PRODUCT STORAGE ERROR (The vial was first punctured on 04-AUG-2022 at 8:15 AM and administerd on 25-AUG-2022 at at 8:30 AM) and NO ADVERSE EVENT (No adverse event) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9237B) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Aug-2022 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2022 at 8:30 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pediatric patient received dose greater than 12 hour post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was first punctured on 04-AUG-2022 at 8:15 AM and administerd on 25-AUG-2022 at at 8:30 AM) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pediatric patient received dose greater than 12 hour post puncture), PRODUCT STORAGE ERROR (The vial was first punctured on 04-AUG-2022 at 8:15 AM and administerd on 25-AUG-2022 at at 8:30 AM) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Pediatric patient received dose greater than 12 hour post puncture) and PRODUCT STORAGE ERROR (The vial was first punctured on 04-AUG-2022 at 8:15 AM and administerd on 25-AUG-2022 at at 8:30 AM).    No relevant concomitant medications were reported.  It was reported that number of doses were 3 doses. On 03-AUG-2022 the vial was initially stored in the refrigerator. Post puncture vial was stored in the fridge. Vial did not undergone any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 to 25 degree centigrade = 46 to 77 degree Farenheit) was 5-10 minutes just to draw up the doses.  Treatment medication was not provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-635837, US-MODERNATX, INC.-MOD-2022-635851 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-635837:Patient 1 US-MODERNATX, INC.-MOD-2022-635851:Patient 3
Via interpreter services in Spanish: after returning home after visit for 6 mo well child appt pt turned white and unresponsive, called EMS and taken to hospital.
Within 24 hours post vax, the pt developed an injection site reaction characterized by swelling, redness, and induration. This is one of two pts from this facility who developed an injection site reaction following receipt of vax.